ARS Pharmaceuticals (SPRY) Q3 2025 Earnings

Aug 13Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.46
-0.15
0.17
0.48

Details

Expected EPS
-0.45805
Actual EPS
-0.46
Surprise EPS
-0
Surprise Percent
-0.43%

Description

⁨ARS Pharmaceuticals⁩ (⁦SPRY⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts